Immunometabolic Circuits in Cardiovascular Remodeling: Organelle Stress, Cellular Reprogramming, and Therapeutic Targeting
Metabolic dysfunction and chronic inflammation are tightly interconnected drivers of cardiovascular remodeling. Lipid overload, hyperglycemia, insulin resistance, mitochondrial stress and gut-derived metabolites activate inflammatory pathways such as TLR4–NF-κB, JNK/mTORC1, cGAS–STING and the NLRP3 inflammasome. In turn, inflammatory mediators impair substrate utilization, mitochondrial homeostasis and insulin signaling, thereby promoting endothelial dysfunction, immune-cell metabolic reprogramming, fibroblast activation and progressive cardiac injury. This review summarizes key immunometabolic mechanisms underlying atherosclerosis, myocardial ischemia–reperfusion injury, heart failure and diabetic cardiomyopathy, with particular emphasis on interconnected mitochondrial, endoplasmic-reticulum and lysosomal stress responses, immune-cell metabolic reprogramming, inflammasome and cGAS–STING signaling, and gut–heart communication. Single-cell and spatial omics are integrated as an evidence layer to resolve disease-associated cell states and inflammatory tissue niches. We further discuss how established therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, statins and colchicine, as well as emerging approaches targeting inflammasome activation, mitochondrial dysfunction and immune-metabolic pathways, may modulate these cellular and molecular circuits and inform future biomarker-guided therapeutic strategies.
Authors
- Kun Wang
- Qian Meng
- Haoxuan Wang
- Sumin Yang
- Meihua Zhang
- Yinghui Li
Institutions
- Qingdao University (CN)
- National Health and Family Planning Commission (CN)
- Affiliated Hospital of Qingdao University (CN)
- Shandong Maternal and Child Health Hospital (CN)
Publication Details
- Journal
- Inflammation
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s10753-026-02618-z
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harbin Medical University